Abstract: The invention relates to the use of morpholino-nucleosides of formula: in which R1 represents a nucleic base and R2 represents a group corresponding to one of the following formulae: —(CH2)n—NH2 —(CH2)n—SH —(CH2)n—COOH —(CH2)n—OH —(CH2)n—NH—R3 —(CH2)n—SR3 —(CH2)n—CO—R3 —(CH2)n—OR3 in which n is an interger ranging from 1 to 12 and R3 is a group derived from a label, from a protein, from an enzyme, from a fatty acid or from a peptide, as chain terminators in a process of DNA or RNA sequencing by the Sanger method, or for the labelling of DNA or RNA fragments.

Abstract: The invention relates to signatures obtained by a method for analyzing nucleic acid, wherein said nucleic acids are partially sequenced, not using all 4 chain extension terminators, a signature is generated, corresponding to the partial sequence, said signature being compared with other theoretical or actual signatures to analyze said nucleic acid.

Abstract: The invention relates to the use of morpholino-nucleosides of formula: in which R1 represents a nucleic base and R2 represents a group corresponding to one of the following formulae: —(CH2)n—NH2 —(CH2)n—SH —(CH2)n—COOH —(CH2)n—OH —(CH2)n—NH—R3 —(CH2)n—SR3 —(CH2)n—CO—R3 —(CH2)n—OR3 in which n is an interger ranging from 1 to 12 and R3 is a group derived from a label, from a protein, from an enzyme, from a fatty acid or from a peptide, as chain terminators in a process of DNA or RNA sequencing by the Sanger method, or for the labelling of DNA or RNA fragments.

Abstract: The invention relates to the use of morpholino-nucleosides of formula: in which R1 represents a nucleic base and R2 represents a group corresponding to one of the following formulae: —(CH2)n—NH2 —(CH2)n—SH —(CH2)n—COOH —(CH2)n—OH —(CH2)n—NH—R3—(CH2)nS—R3 —(CH2)n—CO—R3 —(CH2)n—OR3 in which n is an integer ranging from 1 to 12 and R3 is a group derived from a label, from a protein, from an enzyme, from a fatty acid or from a peptide, as chain terminators in a process of DNA or RNA sequencing by the Sanger method, or for the labelling of DNA or RNA fragments.

Abstract: The invention relates to the use of morpholino-nucleosides of formula: 1

Abstract: A method of making the compound CuInSe.sub.2 (CIS) by depositing a precursor of the compound at least partly electrolytically on a substrate and forming CuInSe.sub.2 by thermal reaction.

Abstract: Multilayer piezoactuators are made by stacking and pressing alternating layers of piezoceramic material and interdigital electrode material. The electrode structure is provided with pressure protected boundary discontinuities which form areas in which electrodes edges do not make contact with the common electrical collectors of the piezoactuators and in which the piezoceramic layers are prevented from touching one another.

Abstract: Durable glow-plugs utilize, for the heating constitutent material of the heater component of ceramic ignition glow-plugs, admixtures comprising a ceramic phase whose thermal expansion factor is substantially equal to that of the insulator components of the plug and, as a homogeneous dispersion therein, a particulate metal conducting phase whose particles are small enough to keep the internal stresses due to any differences in the thermal expansion factors of the ceramic and the metal particles below a limit at which the ceramic phase may crack or fracture.